Sierra Oncology, Inc. Common Stock
SRRA
SRRA was delisted on the 30th of June, 2022.
47 hedge funds and large institutions have $240M invested in Sierra Oncology, Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 13 increasing their positions, 3 reducing their positions, and 9 closing their positions.
333% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 3
100% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 9
24% more funds holding
Funds holding: 38 → 47 (+9)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
10% less capital invested
Capital invested by funds: $268M → $240M (-$28M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$7.49M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$5.98M |
| 3 |
GT
Greenleaf Trust
Kalamazoo,
Michigan
|
+$1.59M |
| 4 |
RIM
RS Investment Management
San Francisco,
California
|
+$1.29M |
| 5 |
QF
QVT Financial
New York
|
+$1.18M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCM
Hayman Capital Management
Dallas,
Texas
|
-$8.66M |
| 2 |
Jennison Associates
New York
|
-$3.09M |
| 3 |
VM
VHCP Management
New York
|
-$2.96M |
| 4 |
Millennium Management
New York
|
-$2.28M |
| 5 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$1.67M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BA
51
BlackRock Advisors
Wilmington,
Delaware
| – | -$1.67M | -2,038 | Closed |
|
|
CS
52
Credit Suisse
Zurich,
Switzerland
| – | -$476K | -580 | Closed |
|
|
BG
53
BlackRock Group
London,
United Kingdom
| – | -$198K | -241 | Closed |
|
|
BIM
54
BlackRock Investment Management
Wilmington,
Delaware
| – | -$109K | -133 | Closed |
|
55
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$103K | -125 | Closed |
|
56
UBS Group
Zurich,
Switzerland
| – | -$8K | -10 | Closed |
|
SRRA Hedge Fund Activity: Q4 2015 in Review
47 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Sierra Oncology, Inc. Common Stock (SRRA) for Q4 2015, worth a combined $240M — down 10% from $268M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new SRRA positions and 9 closed out — a net gain of 9 holders — while 13 added to existing stakes and 3 trimmed.
The largest buyer was Deerfield Management, adding an estimated $7.49M. The largest seller was Hayman Capital Management, exiting entirely with an estimated $8.66M sold.
- 47 institutional investors held Sierra Oncology, Inc. Common Stock (SRRA) as of Q4 2015, up from 38 in Q3 2015.
- Funds reported $240M of Sierra Oncology, Inc. Common Stock stock for Q4 2015, down 10% quarter-over-quarter.
- 18 funds opened new Sierra Oncology, Inc. Common Stock positions in Q4 2015 and 9 closed out, a net change of +9 holders.
- The largest Sierra Oncology, Inc. Common Stock buyer in Q4 2015 was Deerfield Management, an estimated $7.49M added.
- The largest Sierra Oncology, Inc. Common Stock seller in Q4 2015 was Hayman Capital Management, an estimated $8.66M sold.
Based on aggregated 13F filings for Q4 2015.